Publication | Closed Access

Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies

Tumor BiologyMedicineIntralesional ApplicationImmunologyCell DeathPathologyImmune Checkpoint InhibitorAdvanced MalignanciesCancer TreatmentOncologyMalignant DiseaseTumor MicroenvironmentCancer Research